The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: https://www.clintonhealthaccess.org
CHAI, in partnership with its India affiliate the William J Clinton Foundation (WJCF), has been working in India since 2004 in partnership with and under the guidance of the Ministry of Health and Family Welfare (MoHFW) both at the central and state levels on an array of high priority initiatives aimed at improving health outcomes. Currently, WJCF/CHAI work across projects to expand access to quality care and treatment for HIV/AIDS, Hepatitis-C, tuberculosis, cancer, health financing and immunization. Additionally, WJCF/CHAI are supporting the government of Madhya Pradesh (MP) on large-scale programs to arrest childhood and maternal mortality due to malnutrition, anemia, diarrhea and pneumonia, and helping increase access to quality Family Planning services.
India accounts for more than a quarter of the global TB burden with estimated 2.8 million cases annually. Whilst the National Tuberculosis Elimination Programme (NTEP) has been effective in expanding care through the public sector, a majority of patients access care in the private sector where significant gaps across the care cascade, diagnostic delays, irrational and non-standardized regimens and catastrophic health expenditure continue to hamper progress. The country has therefore committed itself to an ambitious and far reaching agenda of eliminating tuberculosis by 2025.
CHAI has been supporting this ambitious agenda by providing catalytic support through technical assistance, increasing awareness, expanding availability of new tools viz diagnostics and drugs, and, research/project implementation.
CHAI is seeking a highly motivated individual with outstanding credentials and demonstrated problem-solving abilities for the role of Manger TB. They will manage key verticals within the TB programs portfolio and collaborate closely with a multitude of internal and external stakeholders in driving impactful programs that expand access for the patient. The Manager will directly support design and implementation of innovative pilots to expand access to diagnostics and treatment. The pilots would range from Latent TB Infection (LTBI), Drug-sensitive TB to Drug-resistant TB (DR-TB). This will include expanding access to newer diagnostics/drugs through excellence in service delivery, improvement in programmatic management, and development of guidelines and operational plans. They must be able to function independently and flexibly and have a strong commitment to excellence.
The Manager will report into a Senior Manager within the TB portfolio at Delhi. A team of Associates and Analysts will directly report to the Manager.